AnalystBook Research · Company Intelligence

Hims & Hers Health, Inc.

HIMSNYSE

Built from Hims & Hers Health, Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

The read at a glance

Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.

  • Distress risk · Altman Z-Score 2.00 grey zone — between safe and distressedWatch
  • Earnings-manipulation signal · Beneish M 0.16 flag raised, worth a closer lookWatch
  • Earnings quality 87/100 accruals in line with cashOK

Where the revenue comes from

Fiscal 2024, as Hims & Hers Health, Inc. reports it. History and quarterly detail are in the app.

  • Sales Channel Directly To Consumer$1.4B
  • Sales Channel Through Intermediary$38.6M

Leadership changes

From Hims & Hers Health, Inc.'s own filings, the day they're filed.

  • Irene Becklund · Chief Accounting Officer · departureeff. 2026-10-09
  • Melissa Baird · Chief Operating Officer · departureeff. 2025-04-21
  • Christopher Payne · appointmenteff. 2024-11-15

Latest filings

  • 10-Q · Quarterly report2026-08-10
  • 8-K · Company announcement2026-08-10
  • 8-K · Company announcement2026-07-17
  • 8-K · Company announcement2026-07-01
  • 8-K · Company announcement2026-06-15
In the full recordFree for 14 days
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Hims & Hers Health, Inc., every answer cited to the official filings🔒
  • The Intelligence Brief — added when Hims & Hers Health, Inc.'s brief passes our SEC-figure check🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.